+ Watch MDTH
on My Watchlist
A healthcare provider focused primarily on the diagnosis and treatment of cardiovascular disease.
Liquidating, properties should be worth fifty percent more then the current price. High quality specialty hospitals.
interesting stock:low psbut no return on equity data available
down $4 to $22
MedCath continues to expand its base of cardiac specialty hospitals. Trades at a discount to peers on EV/Ebitda basis. New management has solidified operations and added cost controls. Long term cardiac care is in the sweet spot of serving an aging Baby Boomer generation.
A David Nierenberg pick... many other good institutions are buying it up.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions